BSX - Boston Scientific Corp.
Close
81.79
1.120 1.369%
Share volume: 7,629,333
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$80.67
1.12
1.39%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-11-01 | 2024-02-20 | 2024-05-01 | 2024-08-01 | |
| Total revenue | 3.170 B | 3.242 B | 3.389 B | 3.599 B | 3.527 B | 3.725 B | 3.856 B | 4.120 B | |
| Cost of revenue | 979.000 M | 1.011 B | 1.040 B | 1.058 B | 1.101 B | 1.146 B | 1.209 B | 1.270 B | |
| Gross profit | 2.191 B | 2.231 B | 2.349 B | 2.541 B | 2.426 B | 2.579 B | 2.647 B | 2.850 B | |
| 1.83% | 5.29% | 8.17% | -4.53% | 6.31% | 2.64% | 7.67% | |||
| Operating expenses | 1.471 B | 1.493 B | 1.552 B | 1.713 B | 1.598 B | 1.741 B | 1.730 B | 1.829 B | |
| Selling general and admin | 1.132 B | 1.163 B | 1.215 B | 1.354 B | 1.242 B | 1.379 B | 1.364 B | 1.446 B | |
| Research and development | 339.000 M | 330.000 M | 337.000 M | 359.000 M | 356.000 M | 362.000 M | 366.000 M | 383.000 M | |
| Total expenses | 2.663 B | 2.716 B | 2.806 B | 2.993 B | 2.918 B | 3.106 B | 3.163 B | 3.321 B | |
| 1.99% | 3.31% | 6.66% | -2.51% | 6.44% | 1.84% | 5.00% | |||
| Operating income | 507.000 M | 526.000 M | 583.000 M | 606.000 M | 609.000 M | 619.000 M | 693.000 M | 799.000 M | |
| Ebit | 507.000 M | 526.000 M | 583.000 M | 606.000 M | 609.000 M | 619.000 M | 693.000 M | 799.000 M | |
| Pretax income | 244.000 M | 396.000 M | 443.000 M | 426.000 M | 608.000 M | 509.000 M | 606.000 M | 420.000 M | |
| 62.30% | 11.87% | -3.84% | 42.72% | -16.28% | 19.06% | -30.69% | |||
| Income tax | 57.000 M | 257.000 M | 131.000 M | 156.000 M | 105.000 M | 0.000 | 115.000 M | 98.000 M | |
| Net income basic | 174.000 M | 123.000 M | 300.000 M | 261.000 M | 505.000 M | 504.000 M | 495.000 M | 324.000 M | |
| -29.31% | 143.90% | -13.00% | 93.49% | -0.20% | -1.79% | -34.55% | |||
| Net income | 174.000 M | 123.000 M | 300.000 M | 261.000 M | 505.000 M | 504.000 M | 495.000 M | 324.000 M | |
| -29.31% | 143.90% | -13.00% | 93.49% | -0.20% | -1.79% | -34.55% |